Jeffrey R. Whiteaker

Effects of meteorological conditions on aerosol composition and mixing state in Bakersfield, CA.

Detection of pesticide residues on individual particles.

Quantitative determination of heme for forensic characterization of bacillus spores using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Complete sequences of small acid-soluble proteins from Bacillus globigii.

Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers.

Head-to-head comparison of serum fractionation techniques.

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

The evolving role of mass spectrometry in cancer biomarker discovery.

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.

An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.

Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.

Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.

Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry.

The increasing role of mass spectrometry in quantitative clinical proteomics.

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.

Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.

Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.

A targeted proteomics-based pipeline for verification of biomarkers in plasma.

Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.

Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry.